Ropes & Gray represented GHO Capital Partners LLP, a European health care specialist investor, in its acquisition of DNA Diagnostics Center (DDC), a leading provider of specialist DNA-based diagnostic services, for €104 million. The acquisition was announced Oct. 13. Further details of the transaction were not disclosed.
DDC's platform technology offers a wide range of products in the fields of biological family relationship testing, veterinary services, forensic services and medical applications for the pharmaceutical industry, including cell-line authentication. The company has European operations based in London and U.S. operations based in Fairfield, Ohio.
GHO Capital was founded in 2014 as a health care investment advisor based in London and targets fast-growing investment opportunities in Europe. This is the first deal from GHO Capital’s new fund.
The Ropes & Gray team was led by private equity partner Neill Jakobe (Chicago) and included tax partner Elaine Murphy (Boston); health care partner Deborah Gersh (Chicago); life sciences partner Albert Cacozza (Washington, D.C.); finance partner Alexander Zeltser (New York); real estate & environmental partner Peter Alpert (Boston); business and securities litigation partner William Sussman (New York); antitrust counsel Deidre Johnson (Boston) and life sciences counsel Kellie Combs (Washington, D.C.).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.